The Necrosis (not to be confused with the Noceros) is the newest monster IGG has introduced to Lords Mobile, and it has proven to be one of the most controversial monsters in recent history. While defeating the monster is mainly irrelevant, since tactics from similar monsters still apply, the big...
Supply chains are difficult; pharma supply chains are even more difficult. But the recent pandemic era has taught us that the most essential thing is better medical asset tracking — transporting the right medical equipment, at the right time, to the right place and people. Nothing is more critical than an oxygen cylinder when a patient struggles to breathe or a perfectly functioning patient monitor when a patient has had a heart attack.
The urgency of the requirement itself makes medical asset tracking one of the most essential and challenging tasks to handle in healthcare supply chains. Let us look at how medical asset tracking works and what kind of a system would best work, even in a whirlwind situation.
Regular readers will know my position on this issue – I do not consider it appropriate at this time (or, potentially, ever) to grant patents for inventions devised entirely by automated means, such that there is no human inventor. I have written an article targeted to a more general audience, which has been published by InnovationAus, providing an overview of the Australian case, and broadly discussing my concerns. Here I will be going into more detail of the arguments presented at the recent hearing, and why I think it would be very unfortunate if Justice Beach were to decide that this is a suitable case for judicial development of the law to embrace machine inventors, as he is being encouraged to do by Thaler.
I was able to attend the hearing virtually, since it was being held via web conference. Thaler’s team, led by experienced and highly-regarded barrister David Shavin QC, appeared in person in the Melbourne courtroom with Justice Beach, while the Commissioner of Patents was represented by Hamish Bevan, appearing via video from Sydney (subject to restrictions, due to an ongoing COVID outbreak). Although I disagree with the proposition, I thought that Mr Shavin presented a persuasive argument that the relevant provisions of the Australian Patents Act 1990 can, and should, be interpreted to encompass non-human inventors, and that Mr Bevan perhaps did not do enough to counter this argument. I formed the impression that Justice Beach just might be minded to ‘develop’ the Australian law to permit patent applications having no human inventor, in part because he was not presented with any particularly good reasons not to do so.
As FaZe Clan members and influencers such as Youtuber Bryan Quang “RiceGum” Le and Sommer Ray, who were involved in promoting the fake crypto token charity Save The Kids, deal with the fallout from their involvement (Frazier “FaZe Kay” Khattri was removed from the organization on July 1, while three others were suspended), the community […]
CoinFund’s Investment Thesis for MoonbeamThis week marks a momentous time with Moonbeam’s Kusama parachain Moonriver winning one of the first parachain auction slots,...
President of the International Publishers’ Association, Sheika Bodour bint Sultan Al Qasimi discusses the challenges confronting publishers in the post-COVID era.
Oxford Instruments NanoScience is partnering in a three-year project to create and develop the UK's first quantum computer capable of running end-user applications in the cloud